We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

23 hedge funds and large institutions have $387K invested in Zomedica Corp. in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

75% less funds holding

Funds holding: 93 → 23 (-70)

96% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 72

97% less capital invested

Capital invested by funds: $11.1M → $387K (-$10.7M)

Holders
23
Holders Change
-70
Holders Change %
-75.27%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
72
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
+$578K
2
ASN
Advisory Services Network
Georgia
+$12.8K
3
RPGK
Retirement Planning Group (Kansas)
Kansas
+$1.24K
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$319
5
RF
Rossby Financial
Florida
+$12

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$5.77M
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.19M
3
BlackRock
BlackRock
New York
-$1.18M
4
Renaissance Technologies
Renaissance Technologies
New York
-$494K
5
UBS Group
UBS Group
Switzerland
-$472K
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
1
Ancora Advisors
Ohio
$274K +$578K +4,720,121 New
BCI
2
Brinker Capital Investments
Pennsylvania
$20.7K – – –
OPS
3
Orion Portfolio Solutions
Nebraska
$20.7K – – –
ASN
4
Advisory Services Network
Georgia
$17.2K +$12.8K +104,677 +54%
SWM
5
Spire Wealth Management
Virginia
$13.1K -$800 -6,533 -3%
Commonwealth Equity Services
6
Commonwealth Equity Services
Massachusetts
$10K +$319 +2,600 +1%
PRTG
7
Post Resch Tallon Group
New York
$8.85K – – –
JWM
8
Jackson Wealth Management
Florida
$8K – – –
GJIA
9
Glass Jacobson Investment Advisors
Maryland
$6.34K – – –
PCIA
10
Prime Capital Investment Advisors
Kansas
$2.27K – – –
SAW
11
Signal Advisors Wealth
Michigan
$1.46K – – –
Cerity Partners
12
Cerity Partners
New York
$1.16K – – –
WS
13
Wedbush Securities
California
$1K – – –
CSP
14
Cary Street Partners
Virginia
$655 – – –
RPGK
15
Retirement Planning Group (Kansas)
Kansas
$589 +$1.24K +10,150 New
GWM
16
Grand Wealth Management
Michigan
$580 – – –
TWC
17
TD Waterhouse Canada
Ontario, Canada
$55 – – –
FFA
18
Farther Finance Advisors
California
$39 – – –
CB
19
CNB Bank
Pennsylvania
$17 – – –
HCP
20
Hexagon Capital Partners
Arkansas
$16 – – –
BWL
21
Bogart Wealth LLC
Virginia
$10 – – –
RF
22
Rossby Financial
Florida
$5 +$12 +100 New
Vanguard Group
23
Vanguard Group
Pennsylvania
– -$5.77M -48,078,677 Closed
Geode Capital Management
24
Geode Capital Management
Massachusetts
– -$1.19M -9,885,333 Closed
BlackRock
25
BlackRock
New York
– -$1.18M -9,821,071 Closed
1
2 3 4

ZOM Hedge Fund Activity: Q1 2025 in Review

23 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2025, worth a combined $387K — down 97% from $11.1M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of ZOM and 3 opened new positions — a net loss of 69 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Ancora Advisors, opening a new position worth an estimated $578K. The largest seller was Vanguard Group, exiting entirely with an estimated $5.77M sold.

  • 23 institutional investors held Zomedica Corp. (ZOM) as of Q1 2025, down from 93 in Q4 2024.
  • Funds reported $387K of Zomedica Corp. stock for Q1 2025, down 97% quarter-over-quarter.
  • 3 funds opened new Zomedica Corp. positions in Q1 2025 and 72 closed out, a net change of -69 holders.
  • The largest Zomedica Corp. buyer in Q1 2025 was Ancora Advisors, an estimated $578K added.
  • The largest Zomedica Corp. seller in Q1 2025 was Vanguard Group, an estimated $5.77M sold.

Based on aggregated 13F filings for Q1 2025.